share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Casey Mark J

Novavax | 4: Statement of changes in beneficial ownership of securities

諾瓦瓦克斯醫藥 | 4：持股變動聲明
SEC announcement ·  03/27 07:05
牛牛AI助理已提取核心訊息
Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the stock's performance.
Mark J. Casey, EVP, CLO & Corporate Secretary of Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the stock's performance.
據報道，Novavax Inc. [NVAX] 執行副總裁、首席運營官兼公司秘書馬克·凱西於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。這些信息對於投資者了解Novavax內部活動至關重要，這可能會影響股票的表現。
據報道，Novavax Inc. [NVAX] 執行副總裁、首席運營官兼公司秘書馬克·凱西於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。這些信息對於投資者了解Novavax內部活動至關重要，這可能會影響股票的表現。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。